CONMED Corp 8-K

What Happened CONMED Corporation filed an 8-K on March 13, 2026, announcing that Andrew Moller will be appointed Interim Principal Financial Officer effective March 15, 2026. Mr. Moller joined CONMED in January 2025 as Vice President, Corporate Controller and became the Company’s Principal Accounting Officer in April 2025.

Key Details

• Effective date: March 15, 2026 (appointment announced March 13, 2026).
• Background: Mr. Moller worked at Smith & Nephew (May 2019–Dec 2024) as Global Controller and CFO Asia‑Pacific; earlier held roles at Stanley Black & Decker (2011–2019), including Director of Internal Audit.
• Qualifications: Certified Public Accountant; MIBS from University of South Carolina; BS in Business Administration from College of Charleston.
• Governance/compensation: No related‑party transactions to disclose, no family ties to the board, and no change to his compensation in connection with the interim appointment.

Why It Matters A change to the company’s principal financial officer can affect investor confidence in financial reporting and internal controls. This is an interim appointment from an internal leader with recent accounting and finance responsibilities at CONMED; the filing notes continuity (no pay change and no related‑party issues), which may reduce disruption. Investors should watch for any follow‑up filings about a permanent CFO appointment or changes to financial reporting responsibilities.